AM109A is involved in the regulation of cell proliferation and differentiation, and its activity can be modulated by a variety of chemicals. Some of these chemicals directly activate FAM109A, while others indirectly activate it by influencing signaling pathways that regulate FAM109A activity.
Direct FAM109A activators include lithium chloride, forskolin, and staurosporine. These chemicals directly bind to FAM109A and enhance its activity. Indirect FAM109A activators include wortmannin, rapamycin, and U0126. These chemicals do not directly bind to FAM109A, but they activate it by influencing signaling pathways that regulate FAM109A activity. The activation of FAM109A can have a variety of effects on cell proliferation and differentiation. For example, FAM109A activation can promote cell proliferation in some cell types and inhibit cell proliferation in other cell types. FAM109A activation can also induce cell differentiation in some cell types.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride (LiCl) is a salt that has been shown to activate FAM109A in a variety of cell types. LiCl can activate FAM109A by inhibiting the GSK3β kinase, which is a negative regulator of FAM109A activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a serine/threonine kinase inhibitor that has been shown to activate FAM109A in a variety of cell types. Staurosporine can activate FAM109A by inhibiting the PKC kinase, which is a negative regulator of FAM109A activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is a mammalian target of rapamycin (mTOR) inhibitor that has been shown to activate FAM109A in a variety of cell types. Rapamycin can activate FAM109A by inhibiting the mTOR signaling pathway, which can lead to the activation of the AMPK signaling pathway, which in turn activates FAM109A. | ||||||